Skip to content
TrialScanner

NCT04648020

Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.

Phase 2/Phase 3TerminatedMNPRLead

Registry record

Lead sponsor
Monopar Therapeutics
Conditions
Chemoradiotherapy-Induced Severe Oral Mucositis
Primary completion
May 14, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04648020 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04648020: Clonidine HCl MBT vs... | TrialScanner